Cerebrospinal fluid matrix-remodeling biomarkers in neonates with myelomeningocele: MMP-9, TIMP-1, and TGF-β1 expression
Child's Nervous System · 04.02.2026 · 42 (1)
DOI: 10.1007/s00381-026-07151-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Child's Nervous System, online erschienen am 04.02.2026. Verfasst von Ibrahim Alataş und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Spina Bifida and Fetal Center, İstanbul Beykent University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 9, Meningomyelocele, Transforming Growth Factor beta1, Tissue Inhibitor of Metalloproteinase-1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Matrix metalloproteinases (MMPs) and their endogenous inhibitors, tissue inhibitors of metalloproteinases, regulate extracellular matrix remodeling and neural tissue homeostasis. Transforming growth factor β1 modulates inflammation, ECM deposition, and tissue repair. Dysregulation of these pathways may contribute to congenital spinal dysraphism. This study quantified cerebrospinal fluid MMP-9, TIMP-1, and TGF-β1 in neonates with myelomeningocele and evaluated their potential as pathogenic mediators or biomarkers. METHODS: Preoperative CSF samples were collected from 48 neonates with isolated myelomeningocele (Group 1) and 24 age-matched controls with sterile CSF (Group 2). MMP-9, TIMP-1, and TGF-β1 concentrations were measured via ELISA. Intergroup differences were analyzed, and Pearson correlation assessed relationships among biomarkers. RESULTS: CSF MMP-9 levels were significantly elevated in neonates with myelomeningocele compared to controls (57.12 ± 64.19 ng/mL vs. 11.29 ± 6.79 ng/mL; p < 0.05). TIMP-1 (368.78 ± 220.08 ng/mL vs. 450.04 ± 390.22 ng/mL) and TGF-β1 (2.32 ± 1.44 ng/mL vs. 2.524 ± 1.07 ng/mL) did not differ significantly. MMP-9 correlated positively with TIMP-1 across all subjects (p < 0.05) and with TGF-β1 within the myelomeningocele group (p < 0.05), indicating coordinated regulation of ECM degradation and fibrogenic signaling. CONCLUSION: Elevated CSF MMP-9 in neonates with myelomeningocele suggests dysregulated ECM remodeling may be associated with neural tube malformation. MMP-9 may serve as a biomarker of ECM dysregulation, providing insights into the pathogenesis of congenital spinal dysraphism and identifying possible targets for future therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Spina Bifida and Fetal Center, İstanbul Beykent University, Istanbul, Turkey.
- Department of Neurosurgery, Ege University Medical Faculty Hospital, Izmir, 35100, Turkey. larisaandradaay@gmail.com.
- Department of Pediatrics, Medicana Ataşehir, Istanbul, Bornova, Turkey.
- Department of Pediatrics, Division of Neonatology, University of Health Sciences Istanbul Research and Training Hospital, Istanbul, Turkey.
- Department of Pediatrics, Beykent University, Istanbul, Turkey.
- Department of Neurosurgery, Giresun Research and Health Hospital, Giresun, Turkey.
Zitieren
APA
Alataş, I., Ay, L. A., Erdinç, H. K., Kara, N., Çelik, C., Çetin, E., Sezen, G. B., Özel, Ş. K., Cetinkaya, M., Atak, P. G., & Görmüş, U. (2026). Cerebrospinal fluid matrix-remodeling biomarkers in neonates with myelomeningocele: MMP-9, TIMP-1, and TGF-β1 expression. Child's Nervous System, 42(1). https://doi.org/10.1007/s00381-026-07151-w
Vancouver
Alataş I, Ay LA, Erdinç HK, Kara N, Çelik C, Çetin E, et al. Cerebrospinal fluid matrix-remodeling biomarkers in neonates with myelomeningocele: MMP-9, TIMP-1, and TGF-β1 expression. Child's Nervous System. 2026;42(1). doi:10.1007/s00381-026-07151-w
BibTeX
@article{Alata2026,
author = {Alataş, Ibrahim and Ay, Larisa Andrada and Erdinç, Hakkı Kemal and Kara, Nursu and Çelik, Cenk and Çetin, Ece and Sezen, Gülseli Berivan and Özel, Şeyhmus Kerem and Cetinkaya, Merih and Atak, Palmet Gün and Görmüş, Uzay},
title = {Cerebrospinal fluid matrix-remodeling biomarkers in neonates with myelomeningocele: MMP-9, TIMP-1, and TGF-β1 expression},
journal = {Child's Nervous System},
year = {2026},
volume = {42},
number = {1},
doi = {10.1007/s00381-026-07151-w}
}
EUVIMED